NIH Bioanalysis Testing Services 2015-2020

The National Institutes of Health established this Master IDIQ with the National Center for Advancing Translational Sciences on September 15, 2015, for bioanalysis testing services on government-furnished small molecules and samples, with a shared ceiling of $20 million; ordering closed September 14, 2020, and the vehicle is no longer active.

The solicitation originally anticipated 3–5 multiple awards under partial small-business set-aside; all 52 task orders awarded, however, carried no set-aside designation. Work centers on in vitro and in vivo pharmacokinetic analysis, ADME (absorption, distribution, metabolism, excretion) testing, metabolite identification, stability assays, high-throughput chemical analysis, and brain exposure determination in preclinical models. Task orders were typically firm-fixed-price, ranging from under $1,000 to roughly $343,000, with most individual orders in the $3,000–$50,000 band.

Ordering activity peaked in 2017 (26 orders) and declined thereafter; the most recent order was placed in August 2018. All $3.8 million in combined potential value across 52 orders is obligated. Five prime contractors hold all awards: Pharmaron, Inc. dominates by order count (27 orders, $925 thousand), while Opans LLC holds the largest share by dollar value ($1.8 million across 4 orders). Quintara Discovery, Inc., Crown Bioscience, Inc., and Charles River Laboratories, Inc. round out the field.

Customer concentration is high: the National Institute on Drug Abuse (NIDA) placed 43 of 52 orders ($2.3 million combined potential value), with the National Center for Advancing Translational Sciences accounting for the remaining 9 orders ($1.6 million). Both customers are components of NIH.

The vehicle's five-year ordering window closed in September 2020. No new task orders have been issued since 2018, signaling that this IDIQ is fully matured and no longer available for new work.

The National Center for Advancing Translational Sciences (NCATS) is the newest of 27 Institutes and Centers (ICs) at the National Institutes of Health (NIH).The contractor shall perform bioanalysis testing services of the government's samples in support of the research conducted at NCATS/NCGC. Specifically, the contractor shall perform bioanalysis testing services on the government furnished small molecules and samples and provide a report to the government of the results of the services.